A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3
NCT06507462 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 460
Last updated 2025-02-11
Summary
The goal of this observational study is to construct a predictive model for improving the diagnostic accuracy in patients with PI-RADS score of 3. The main aims of this study are:
* Construct a diagnostic model of patients with PI-RADS of score.
* Internal and external validation of the model.
* Decision curve analysis. The data of participants was collected retrospectively.
Conditions
Interventions
- PROCEDURE
-
prostate biopsy
All patients were required to underwent transperineal prostate biopsy and have corresponding pathological diagnosis results.
Sponsors & Collaborators
-
Anhui Provincial Hospital
lead OTHER_GOV
Principal Investigators
-
Jun Xiao, Pro. · The First Affiliated Hospital of USTC
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2024-10-31
- Completion
- 2024-10-31
Countries
- China
Study Locations
More Related Trials
-
Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06462508 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT05955677 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer
NCT03927287 ·Status: COMPLETED
-
Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer
NCT06684652 ·Status: RECRUITING ·Phase: NA
-
Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients
NCT03237026 ·Status: RECRUITING
-
Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06756334 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Biological Markers and Advanced Imaging for Prostate Cancer Progression in Active Surveillance
NCT06866041 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed
NCT04462926 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer
NCT06482658 ·Status: COMPLETED ·Phase: NA
-
Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06462495 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate Cancer
NCT06584279 ·Status: RECRUITING
-
Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate Cancer
NCT06509919 ·Status: RECRUITING
-
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer
NCT03789253 ·Status: RECRUITING
-
Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection
NCT03572946 ·Status: UNKNOWN ·Phase: NA
-
Artificial Intelligence-Based Computer-Aided Diagnosis of Prostate Cancer
NCT05513638 ·Status: RECRUITING
-
Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.
NCT06355843 ·Status: SUSPENDED ·Phase: NA
-
The Development and Validation of MRI-AI-based Predictive Models for csPCa
NCT06842264 ·Status: RECRUITING
-
Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer
NCT05333432 ·Status: WITHDRAWN ·Phase: NA
-
Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer
NCT03451812 ·Status: UNKNOWN
-
To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence
NCT06360523 ·Status: RECRUITING ·Phase: NA
-
A Research for Combination of Prostate Health Index (Phi) and mpMRI PI-RADS in the Diagnosis of Prostate Cancer
NCT05179707 ·Status: UNKNOWN
-
Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPV
NCT04251546 ·Status: UNKNOWN
-
Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis
NCT06575361 ·Status: COMPLETED ·Phase: NA
-
Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer
NCT06662708 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate Cancer
NCT06253065 ·Status: COMPLETED